Total Payments
$2,948
2024 Payments
$297.96
Companies
15
Transactions
188
Medicare Patients
1,072
Medicare Billing
$124,120
Payment Breakdown by Category
Food & Beverage$2,922 (99.1%)
Education$26.38 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,922 | 184 | 99.1% |
| Education | $26.38 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,225 | 86 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $888.23 | 49 | $0 (2024) |
| Mylan Specialty L.P. | $264.64 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $235.82 | 14 | $0 (2022) |
| Grifols USA, LLC | $71.31 | 5 | $0 (2018) |
| INOGEN, INC. | $64.60 | 5 | $0 (2024) |
| Philips Electronics North America Corporation | $52.01 | 3 | $0 (2019) |
| Advanced Respiratory, Inc | $26.87 | 2 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $20.31 | 2 | $0 (2017) |
| Covis Pharma GmBH | $19.34 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.96 | 17 | GlaxoSmithKline, LLC. ($151.59) |
| 2023 | $297.89 | 19 | GlaxoSmithKline, LLC. ($103.68) |
| 2022 | $204.30 | 13 | AstraZeneca Pharmaceuticals LP ($102.48) |
| 2021 | $469.37 | 33 | AstraZeneca Pharmaceuticals LP ($183.04) |
| 2020 | $230.22 | 14 | GlaxoSmithKline, LLC. ($102.73) |
| 2019 | $392.79 | 24 | GlaxoSmithKline, LLC. ($172.26) |
| 2018 | $580.54 | 31 | GlaxoSmithKline, LLC. ($275.31) |
| 2017 | $474.99 | 37 | GlaxoSmithKline, LLC. ($196.77) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 03/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: RESPIRATORY | ||||||
| 02/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Respiratory | ||||||
| 11/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $12.41 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 10/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/14/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $8.91 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 09/14/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $6.68 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 202 | 255 | $100,823 | $22,978 |
| 2022 | 5 | 208 | 252 | $108,003 | $27,086 |
| 2021 | 5 | 293 | 361 | $119,565 | $34,907 |
| 2020 | 8 | 369 | 461 | $88,073 | $39,150 |
Total Patients
1,072
Total Services
1,329
Medicare Billing
$124,120
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 197 | $79,422 | $18,211 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $12,531 | $2,810 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $8,307 | $1,813 | 21.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 22 | 22 | $562.99 | $143.66 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 192 | $77,967 | $19,256 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $9,707 | $2,554 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $9,631 | $2,544 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $8,930 | $2,338 | 26.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 12 | 12 | $1,768 | $393.09 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 160 | 218 | $72,581 | $20,381 | 28.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 56 | $23,180 | $7,763 | 33.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $13,121 | $3,851 | 29.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $7,504 | $1,821 | 24.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 48 | 49 | $3,179 | $1,091 | 34.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 184 | 264 | $46,200 | $20,615 | 44.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 35 | 35 | $11,830 | $5,691 | 48.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 35 | 43 | $10,750 | $4,751 | 44.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $6,222 | $2,798 | 45.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $5,200 | $2,223 | 42.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 54 | 57 | $3,591 | $1,452 | 40.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 16 | $2,080 | $920.00 | 44.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $2,200 | $699.16 | 31.8% |
About Dr. Ravi Tandon, MD
Dr. Ravi Tandon, MD is a Pulmonary Disease healthcare provider based in Woonsocket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346399516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ravi Tandon, MD has received a total of $2,948 in payments from pharmaceutical and medical device companies, with $297.96 received in 2024. These payments were reported across 188 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,922).
As a Medicare-enrolled provider, Tandon has provided services to 1,072 Medicare beneficiaries, totaling 1,329 services with total Medicare billing of $124,120. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Woonsocket, RI
- Active Since 01/09/2007
- Last Updated 08/14/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1346399516
Products in Payments
- TRELEGY ELLIPTA (Drug) $740.43
- SYMBICORT (Drug) $289.62
- BREZTRI (Drug) $248.77
- ANORO (Drug) $188.96
- BREO (Drug) $180.10
- DALIRESP (Drug) $124.80
- STIOLTO RESPIMAT (Drug) $102.47
- Perforomist (Drug) $94.85
- YUPELRI (Drug) $92.90
- FASENRA (Biological) $81.70
- STIOLTO (Drug) $80.42
- Yupelri (Drug) $76.89
- Prolastin-C (Biological) $71.31
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $64.60
- AIRSUPRA (Drug) $63.68
- NUCALA (Biological) $55.37
- ANORO ELLIPTA (Drug) $44.09
- inCourage (Device) $31.98
- SPIRIVA RESPIMAT (Drug) $30.69
- BREZTRI AEROSPHERE (Drug) $28.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.